Verified Document

Ciba Vision Group Financial Problems Research Paper

Alcon must learn from such innovative stands, and incorporate these ideas into its own medical offerings in its surgical, pharmaceutical, and vision care products. By bringing the R&D components of all satellite organizations into one entity, it will be able to make use of some of the innovative thinking present at CIBA. However, it must be careful to ensure that this is genuinely a learning effort, and ensure that Alcon does not stifle the values that made CIBA so strong since its founding in the 1980s.

Problem #3: Mix insider insight with outside observation

Generating synergy also requires homogeneous 'tracking' tools to ensure that the different components of the newly merged entity are being judged by the same standards. Currently, management of the company is unified at its regional and national levels, although sales and marketing departments are segmented based upon the specific designation (CIBA or Alcon) of different departments (Chavers & Mota 2010). Some clear benefits can be derived from this structure, given that sales and...

But balancing the need to keep track of overall metrics may be challenging, unless management of all financial data is consolidated under Alcon, to ensure a consistent approach of the company towards costs even while preserving regional integrity of sales and marketing campaigns.
References

Alcon products for eye care and health. (2011). Alcon Official Website. Retrieved May 27, 2011

at http://www.alcon.com/en/alcon-products/index.aspx

Chavers, Gabrielle & Melissa Mota. (2010). Alcon and Novartis complete merger and form new

Alcon division to accelerate global leadership in eye care. Retrieved May 27, 2011 at http://www.alcon.com/en/docs/AlconTradeRelease.pdf

Research and development. (2011). CIBA Vision Official Website. Retrieved May 27, 2011

http://www.cibavision.com/innovation/research-and-development.shtml

Sources used in this document:
References

Alcon products for eye care and health. (2011). Alcon Official Website. Retrieved May 27, 2011

at http://www.alcon.com/en/alcon-products/index.aspx

Chavers, Gabrielle & Melissa Mota. (2010). Alcon and Novartis complete merger and form new

Alcon division to accelerate global leadership in eye care. Retrieved May 27, 2011 at http://www.alcon.com/en/docs/AlconTradeRelease.pdf
http://www.cibavision.com/innovation/research-and-development.shtml
Cite this Document:
Copy Bibliography Citation

Related Documents

Market Driven Management
Words: 25695 Length: 75 Document Type: Term Paper

Pharmaceutical industries have to operate in an environment that is highly competitive and subject to a wide variety of internal and external constraints. In recent times, there has been an increasing trend to reduce the cost of operation while competing with other companies that manufacture products that treat similar afflictions and ailments. The complexities in drug research and development and regulations have created an industry that is subject to intense

Japanese-American Biopharmaceutical Industry in the 21st Century
Words: 20340 Length: 60 Document Type: Term Paper

Japanese-American Biopharmaceutical Industry in the 21st Century Optimizing Ethical Drug Availability Between These Two Pharmaceutical Superpowers" The Japanese-American biopharmaceutical industry represents an ongoing international effort between the two top pharmaceutical markets in the world. These two economic powers provide consumers with a majority share of all pharmaceuticals produced in the world. However, a number of pharmaceutical products that are currently available to U.S. residents are unavailable to Japanese consumers. From a humanitarian perspective, this

Sign Up for Unlimited Study Help

Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.

Get Started Now